Harvard Bioscience's total assets for Q2 2025 were $80.09M, an increase of 0.37% from the previous quarter. HBIO total liabilities were $0.00 for the fiscal quarter, a -100.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.